Press Releases
Search by:
Latest Press Releases   Get News Alerts by RSS
 
> View All Press Releases
RSS
November 20, 2009
U.S. Food and Drug Administration Approves ABILIFY® (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
November 15, 2009
Bristol-Myers Squibb Announces Split-Off of Mead Johnson
November 10, 2009
Bristol-Myers Squibb to Present at Credit Suisse Healthcare Conference
November 10, 2009
Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic
November 05, 2009
FDA Approves Labeling Update for REYATAZ® (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients
October 31, 2009
BARACLUDE® (entecavir) Demonstrated Greater Antiviral Efficacy Compared to Adefovir in New Study of Chronic Hepatitis B Patients with Evidence of Decompensated Cirrhosis
October 31, 2009
Bristol-Myers Squibb and ZymoGenetics Present Final Phase 1b Results for PEG-Interferon Lambda in Hepatitis C
October 29, 2009
Photo
Bristol-Myers Squibb Donation to Benefit Students at The Pennington School and Beyond
October 26, 2009
Medarex, Inc. Announces Expiration of Offer to Repurchase its 2.25% Convertible Senior Notes due May 15, 2011
October 23, 2009
Exelixis and Bristol-Myers Squibb Report New Phase 2 Data for XL184 in Patients With the Most Common and Aggressive Form of Brain Cancer
October 22, 2009
Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter
October 20, 2009
Graphic
New Data Describe Safety of Subcutaneous Administration of ORENCIA® (abatacept) For Patients with Moderate to Severe Rheumatoid Arthritis
October 18, 2009
Photo
ORENCIA® (abatacept) Demonstrated Sustained Clinical Response in a Study of Adult Patients with Moderate to Severe Early Rheumatoid Arthritis (Less Than Two Years Duration)
October 05, 2009
ONGLYZA™ (saxagliptin) Receives Marketing Authorisation In Europe For The Treatment Of Type 2 Diabetes
October 05, 2009
Study Finds That ONGLYZA™ (saxagliptin) When Added To Metformin Was Non-Inferior To JANUVIA (SITAGLIPTIN) When Added To Metformin In Reducing Hemoglobin (HbA1c) In Adults With Type 2 Diabetes Mellitus
October 02, 2009
Bristol-Myers Squibb to Announce Results for the Third Quarter of 2009 on October 22
October 02, 2009
Dapagliflozin Study Demonstrated Significantly Improved Glycemic Control and Weight Reduction in Type 2 Diabetes Patients Inadequately Controlled with Metformin
October 01, 2009
Bristol-Myers Squibb and ZymoGenetics to Present Final Phase Ib Data on PEG-Interferon Lambda at AASLD 2009
October 01, 2009
New Data on Four Bristol-Myers Squibb Compounds to Be Presented at AASLD 2009
September 24, 2009
Medarex, Inc. Issues Notice of Change in Control to Holders of its Convertible Notes
September 23, 2009
Data Presented from Two Phase 3 ERBITUX® Studies in First-Line Metastatic Colorectal Cancer Patients at Joint 15th European Cancer Organisation and 34th European Society for Medical Oncology Multidisciplinary Congress
September 15, 2009
Bristol-Myers Squibb Company Announces Sale to Taisho Pharmaceutical Co Ltd., of Its OTC Assets in Asia Pacific (Excl. China & Japan) and Shares in PT Bristol-Myers Squibb Indonesia Tbk
September 11, 2009
Bristol-Myers Squibb to Present at Morgan Stanley Global Healthcare Unplugged Conference
September 09, 2009
Bristol-Myers Squibb Announces Dividend
September 03, 2009
Bristol-Myers Squibb Announces Acceptance of Submission for Belatacept Biologic License Application
1 2 3 4 5 6 7 8 9 10 11 ... 22
 
Next »
RSS